Partner Steven Lieberman will participate in a panel titled "The Role of Patents in Biopharma v. High-Tech Industries: How Can One Patent System Effectively Accommodate Both?" at the 2020 Joint Annual Meeting of The Sedona Conference Working Group 9 on Patent Damages and Remedies (WG9) and Working Group 10 on Patent Litigation Best Practices (WG10) taking place November 19-20, 2020, online.
The Sedona Conference (TSC) is a nonpartisan, nonprofit 501(c)(3) research and educational institute dedicated to the advanced study of law and policy in the areas of antitrust law, complex litigation, and intellectual property rights. The mission of TSC is to move the law forward in a reasoned and just way through the creation and publication of nonpartisan consensus commentaries and through advanced legal education for the bench and bar.
To learn more about The Sedona Conference, please visit their website at: https://thesedonaconference.org/.